Penn Engineering Secures $7 Million Grant for AI-Driven Personalized Medicine
Researchers from the School of Engineering and Applied Science and the Perelman School of Medicine received a four-year, $7 million grant to develop AI systems that enhance personalized medical treatment. This project aims to improve predictions for treatment responses in diseases such as breast cancer, heart attacks, and sepsis.
The grant is from the Advanced Research Projects Agency for Health (ARPA-H), which supports innovative research to advance health outcomes not achievable through standard methods. Rajeev Alur, a Computer and Information Science professor, will lead the project.
Alur’s team will work closely with clinicians to understand real-world health data and workflows. This collaboration is vital to creating systems that effectively integrate AI into medical practices.
What are the key benefits of using AI in personalized medical treatment according to Rajeev Alur?
Interview with Rajeev Alur on Innovative AI Systems for Personalized Medical Treatment
Interviewer: Thank you for joining us today, Professor Alur. Congratulations on receiving the $7 million grant from ARPA-H! Can you share what inspired you and your team to pursue this project?
Rajeev Alur: Thank you! We’re excited about this opportunity. Our inspiration stems from the urgent need for personalized medicine. In fields like oncology and cardiology, treatment responses can vary dramatically from patient to patient. We want to leverage AI to make more accurate predictions that can help clinicians tailor treatments for better outcomes.
Interviewer: How will the collaboration with clinicians shape the development of these AI systems?
Rajeev Alur: Collaboration with clinicians is crucial. They provide invaluable insights regarding real-world health data and existing workflows. By understanding their challenges and needs, we can design AI systems that seamlessly integrate into medical practice, enhancing rather than disrupting their work.
Interviewer: Could you elaborate on the specific diseases your project aims to address and the expected impact on treatment responses?
Rajeev Alur: We will initially focus on breast cancer, heart attacks, and sepsis. Our goal is to develop AI models that can analyze patient data to predict how individuals will respond to various treatments, potentially improving the efficacy of those treatments and minimizing unnecessary side effects.
Interviewer: The intersection of AI and healthcare has huge implications. What role does the expertise of your co-investigators and the Dean of the Engineering School play in this project?
Rajeev Alur: My co-investigators bring a wealth of knowledge from both engineering and medical backgrounds, which is essential for bridging the gap between technology and clinical practice. Dean Vijay Kumar’s support reinforces the importance of merging AI expertise with clinical knowledge to create systems that are not only technically sound but also practically applicable.
Interviewer: Looking ahead, how is Penn furthering its commitment to AI beyond this grant?
Rajeev Alur: Penn is taking significant steps by introducing a new undergraduate degree in AI and establishing the Penn AI Council. These initiatives aim to foster AI literacy and prepare the next generation of leaders in this transformative field, ensuring that we continue to innovate in healthcare and beyond.
Interviewer: Thank you, Professor Alur, for your insights. We look forward to seeing the advancements from your team in personalized medical treatment.
Rajeev Alur: Thank you for having me! We are eager to contribute to this essential field.
Vijay Kumar, Dean of the Engineering School, emphasized the importance of merging AI expertise with clinical knowledge. Co-investigators include Qi Long, Rajat Deo, Sameed Khatana, Payal Shah, Gary Weissman, Mayur Naik, and Eric Wong, alongside Ravi Parikh from Emory University.
Penn is enhancing its AI initiatives through a new undergraduate degree in AI and establishing the Penn AI Council.